AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Onc.Ai Raises $25 Million Series A Financing Co-Led By Massmutual And Action Potential Venture Capital

Jan 05, 2023•over 2 years ago

Amount Raised

$25 Million

Round Type

series a

San Carlos

Investors

Kd T VenturesDigitalis VenturesBlue Venture FundLife Extension VenturesAction Potential Venture Capital

Description

Onc.AI, a medical technology company developing a novel digital clinical management solution focused on immuno-oncology, announced today it has closed a $25 million Series A financing co-led by MassMutual and Action Potential Venture Capital (a GSK venture fund). Also participating were Life Extension Ventures and all existing investors including Blue Venture Fund, Accomplice, Digitalis Ventures, and KdT Ventures.

Company News

(10 articles)

Thu, 06 Feb 2025 08:00:00 GMT

Onc.AI Awarded FDA Breakthrough Device Designation for Serial CT Response Score Deep Learning Model - Business Wire

Fri, 06 Jun 2025 07:00:00 GMT

Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology - Nature

Wed, 23 Jul 2025 07:00:00 GMT

Personalized Oncology: AI-Powered Precision Medicine for Cancer Patients - AZoRobotics

Mon, 10 Feb 2025 08:00:00 GMT

AI Prognostic Tool for NSCLC Earns FDA Breakthrough Designation - Targeted Oncology

Mon, 03 Feb 2025 08:00:00 GMT

Exploring the role of artificial intelligence in chemotherapy development, cancer diagnosis, and treatment: present achievements and future outlook - Frontiers

Wed, 26 Mar 2025 07:00:00 GMT

C3.ai, Inc. (AI) Partners with PwC to Scale AI-Powered Business Transformation - Yahoo Finance

Mon, 16 Jun 2025 07:00:00 GMT

As AI Dawns in Precision Oncology, 2025 Expected To Be a ‘Turning Point’ - BioSpace

Fri, 18 Oct 2024 07:00:00 GMT

The AI boom in cancer: Game-changer or just hype? - Labiotech.eu

Mon, 21 Apr 2025 07:00:00 GMT

OncLive® Launches Scout, an AI Assistant to Help Oncologists Quickly Access Expert Insights - GlobeNewswire

Fri, 20 Dec 2024 08:00:00 GMT

AI in Oncology Market worth $11.52 billion by 2030 - MarketsandMarkets

FundzWatch™ Score

Medium Activity

4 total signals

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech